Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Activase cleared by FDA for ischemic stroke

June 14, 1996

More glutamate antagonists from NeuroSearch

June 14, 1996

Novo Nordisk synthesizes AMPA antagonists

June 14, 1996

Glutamate antagonists reported by BASF

June 14, 1996

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

Aspartate derivative with antiamnestic activity synthesized

June 14, 1996

More possible Alzheimer's treatment

June 14, 1996

XSB-1E as possible Alzheimer's treatment

June 14, 1996

MF-8622 undergoes preclinical evaluation

June 14, 1996

Warner-Lambert discloses complement C1r protease inhibitors

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....